Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has been assigned a consensus recommendation of “Hold” from the sixteen analysts that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $9.1154.

Several analysts have recently weighed in on the company. Citigroup decreased their price objective on Teladoc Health from $10.00 to $9.00 and set a “neutral” rating on the stock in a report on Friday, January 9th. Evercore ISI reduced their target price on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Barclays assumed coverage on shares of Teladoc Health in a research note on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 price target on the stock. BMO Capital Markets started coverage on shares of Teladoc Health in a report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 price target on the stock. Finally, Zacks Research downgraded shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th.

Teladoc Health Stock Down 3.6%

TDOC stock opened at $4.74 on Friday. Teladoc Health has a twelve month low of $4.70 and a twelve month high of $15.21. The company has a quick ratio of 2.60, a current ratio of 2.70 and a debt-to-equity ratio of 0.71. The company has a market cap of $840.33 million, a PE ratio of -3.70 and a beta of 2.12. The business’s 50-day simple moving average is $6.86 and its 200 day simple moving average is $7.51.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $7.63, for a total transaction of $130,762.94. Following the completion of the transaction, the chief executive officer owned 201,036 shares in the company, valued at $1,533,904.68. This trade represents a 7.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Adam C. Vandervoort sold 5,720 shares of Teladoc Health stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $7.49, for a total value of $42,842.80. Following the sale, the insider directly owned 80,732 shares in the company, valued at $604,682.68. The trade was a 6.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 33,288 shares of company stock worth $251,684. 0.58% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Tejara Capital Ltd bought a new position in shares of Teladoc Health during the fourth quarter valued at $1,114,000. VIRGINIA RETIREMENT SYSTEMS ET Al increased its position in shares of Teladoc Health by 62.3% during the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 243,525 shares of the health services provider’s stock worth $1,705,000 after purchasing an additional 93,450 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $45,000. Hussman Strategic Advisors Inc. lifted its holdings in Teladoc Health by 42.9% during the 4th quarter. Hussman Strategic Advisors Inc. now owns 210,000 shares of the health services provider’s stock valued at $1,470,000 after purchasing an additional 63,000 shares during the last quarter. Finally, Oppenheimer & Co. Inc. boosted its position in Teladoc Health by 6.6% in the fourth quarter. Oppenheimer & Co. Inc. now owns 140,557 shares of the health services provider’s stock valued at $984,000 after buying an additional 8,722 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.